Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
461
-
462
-
463
-
464
Data Sheet 1_Increasing donor kidney age significantly aggravates the negative effect of pretransplant donor-specific anti-HLA antibodies on kidney graft survival.pdf
Published 2025“…Background and hypothesis<p>The presence of donor-specific anti-HLA antibodies before kidney transplantation (preDSAs) is associated with decreased graft survival. The hypothesis that increasing donor kidney age is negatively associated with the impact of preDSA on graft survival was investigated.…”
-
465
-
466
-
467
KEGG enrichment map of differential metabolites (a) and differential abundance score map (b).
Published 2025Subjects: -
468
Detected metabolites (a), volcano plot (b) and scatter plot (c) of differential metabolites.
Published 2025Subjects: -
469
-
470
-
471
-
472
-
473
Data for Figs 8A–8H, 9A–9K, 10A–10I.
Published 2024“…In <i>vivo</i> experiments further showed that PRV UL4 (<sup>132</sup>DVAADAAAEAAAAE<sup>145</sup>) mutated strain (PRV-UL4<sup>mut</sup>) infection did not lead to a significant decrease in viral titers at 12 h. p. i, but it induced lower levels of IL-1β, IL-18, and GSDMD-NT, which led to an alleviated inflammatory infiltration and pathological damage in the lungs and brains, and a lower death rate compared with wild-type PRV strain infection. …”
-
474
-
475
rTsSPc interacted with PGAM5 and increased its protein expression in Caco-2 cells.
Published 2025Subjects: -
476
-
477
-
478
-
479
Alterations of Ceramides, Acylcarnitines, GlyceroLPLs, and Amines in NSCLC Tissues
Published 2024Subjects: -
480
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”